Buscar
Mostrando ítems 51-60 de 488
Gingival primary extranodal non-Hodgkin's lymphoma as the first manifestation of acquired immunodeficiency syndrome
(Amer Acad Periodontology, 2008-03-01)
Background: Non-Hodgkin's lymphomas (NHLs) are a heterogeneous group of lymphoproliferative malignancies that may be associated with acquired immunodeficiency syndrome (AIDS). NHL can disseminate to extranodal sites; ...
Gingival primary extranodal non-Hodgkin's lymphoma as the first manifestation of acquired immunodeficiency syndrome
(Amer Acad Periodontology, 2008-03-01)
Background: Non-Hodgkin's lymphomas (NHLs) are a heterogeneous group of lymphoproliferative malignancies that may be associated with acquired immunodeficiency syndrome (AIDS). NHL can disseminate to extranodal sites; ...
Proliferating cell nuclear antigen (PCNA), p53 and MDM2 expression in Hodgkin's disease
(Associacao Paulista Medicina, 2007-03-01)
CONTEXT and OBJECTIVE: Tumor cells in Hodgkin's disease (HD) express cell proliferation markers that are evaluated according to the oncogenes involved or the expression of their proteins. Correlations between the protein ...
HIV-related lymphoma in a public hospital in Chile. Analysis of 55 cases Linfoma relacionado a infección por virus de la inmunodeficiencia humana en un hospital público de Santiago, Chile
(2012)
Background: Cancer is the third cause of death in patients infected with human immunodefi ciency virus (HIV) and lymphoma is the most common type. Aim: To describe the clinical characteristics, histology, risk factors and ...
Tratamento do linfoma de Hodgkin após falha do transplante autólogo
(Associação Brasileira de Hematologia e Hemoterapia e daSociedade Brasileira de Transplante de Medula Óssea, 2008)
O linfoma de Hodgkin (LH) é uma neoplasia do tecido linfóide de excelente prognóstico, porém, aproximadamente 15% dos pacientes em estádios precoces e 35% dos em estádios avançados progridem após o tratamento inicial. O ...
Brazilian experience using high dose sequential chemotherapy followed by autologous hematopoietic stem cell transplantation for malignant lymphomas
(Associação Brasileira de Hematologia e Hemoterapia e daSociedade Brasileira de Transplante de Medula Óssea, 2011)